|
|
Article: New drug treats newborns with compromised lung function.
- Article from:
- Blood Weekly
- Article date:
- August 8, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 AUG 8 - (NewsRx.com & NewsRx.net) -- Investigators from Duke University Neonatal-Perinatal Research Institute and the Howard Hughes Medical Institute (HHMI) have developed a new drug that appears in preliminary testing to be successful in treating newborns whose lungs are unable to properly oxygenate their blood. The researchers also believe that the drug - called O-nitrosoethanol (ENO) - will prove effective in improving oxygenation in patients with such disorders as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis and sickle cell disease.
The researchers tested ENO on seven Duke newborns with persistent pulmonary hypertension, or high ...